Rajiv Patni - 15 Jan 2025 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role
Director
Signature
/s/ Javier Rodriguez, Attorney-in-Fact for Rajiv Patni
Issuer symbol
BTAI
Transactions as of
15 Jan 2025
Net transactions value
$0
Form type
4
Filing time
16 Jan 2025, 08:04:21 UTC
Previous filing
07 Jun 2024
Next filing
06 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTAI Stock Option (right to buy) Award $0 +44,000 $0.000000 44,000 15 Jan 2025 Common Stock 44,000 $0.3465 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 15, 2025, the Reporting Person was granted an option to purchase 44,000 shares of common stock, which vests in three equal installments on the first three anniversaries of the grant date, subject to his continued service as a Director through the vesting period.